Patents by Inventor WANMENG MU

WANMENG MU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240035057
    Abstract: Disclosed are a construction method and application of a microorganism capable of realizing high production of lacto-N-tetrose, belonging to the field of microbial genetic engineering. The present disclosure employs a strain which has been constructed in the early stage for efficiently producing a precursor lacto-N-triose II as an original strain to synthesize a key gene of the lacto-N-tetrose via over-expression, thus enabling the strain to have a synthesis capability of producing the lacto-N-tetrose. The present disclosure improves the synthesis of the lacto-N-tetrose by screening a high-efficiency ?-1,3-galactosyl transferase gene, and reasonably designing the co-expression of the ?-1,3-galactosyl transferase gene and a key UDP-glucose 4 epimerase gene (galE) for strengthening a UDP-galactose pathway on a vector pCDFDuet-1. In a shake flask experiment, the lacto-N-tetrose production capacity of Escherichia coli is 3.04 g/L. The lacto-N-tetrose yield in a 3 L fermentation tank reaches 25.49 g/L.
    Type: Application
    Filed: October 12, 2023
    Publication date: February 1, 2024
    Inventors: Wanmeng Mu, Yingying Zhu, Zeyu Li, Wenli Zhang
  • Publication number: 20240035058
    Abstract: Disclosed are a construction method and application of a microorganism capable of realizing high production of lacto-N-neotetraose, belonging to the field of microbial genetic engineering. Coding genes of ?-1,3-acetyl glucosamine transferase, ?-1,4-galactosyl transferase and/or UDP-glucose 4 epimerase are over-expressed on the basis of a strain which is previously constructed by the team and is subjected to related-gene knockout, thus enabling the strain to have a synthesis capability of producing the lacto-N-neotetraose. The present disclosure accurately regulates the carbon flux of a metabolic pathway and relieves the metabolic stress by screening the high-efficiency ?-1,4-galactosyl transferase gene and regulating the expression of IgtA, Aa-?-1,4-GalT and galE in a lacto-N-neotetraose synthesis pathway in a combined manner. In a shake flask experiment, the lacto-N-neotetraose production capacity of Escherichia coli is 0.91 g/L. The lacto-N-neotetraose yield in a 3 L fermentation tank reaches 12.14 g/L.
    Type: Application
    Filed: October 12, 2023
    Publication date: February 1, 2024
    Inventors: Wanmeng Mu, Yingying Zhu, Guocong Luo, Wenli Zhang
  • Patent number: 10829755
    Abstract: A genetically engineered arginine deiminase reconstructed by site-directed mutagenesis belongs to the technical field of genetic engineering technology. Its amino acid sequence is shown as SEQ ID No. 1. In the amino acid sequence of the arginine deiminase reconstructed by site-directed mutagenesis, glycine at position 264 is mutated to proline, compared to an amino acid sequence of native arginine deiminase. Compared with wild type enzyme, the effective pH range effect of the mutated arginine deiminase according to the present invention is broadened to a certain extent, and especially a good enzyme activity is achieved at physiological pH 7.4. With the broadening of the effective pH effect range, the mutant enzyme still has higher stability under the condition of pH 5.5-7.5.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: November 10, 2020
    Assignee: Jiangnan University
    Inventors: Tao Zhang, Bo Jiang, Hangyu Jiang, Wanmeng Mu, Ming Miao
  • Patent number: 10815470
    Abstract: An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: October 27, 2020
    Assignee: Jiangnan University
    Inventors: Tao Zhang, Bo Jiang, Hangyu Jiang, Wanmeng Mu, Ming Miao
  • Publication number: 20200109391
    Abstract: An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 9, 2020
    Inventors: Tao ZHANG, Bo JIANG, Hangyu JIANG, Wanmeng MU, Ming MIAO
  • Patent number: 10612016
    Abstract: The present invention relates to an improved variant of a D-psicose 3-epimerase and its uses.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: April 7, 2020
    Assignee: ROQUETTE FRERES
    Inventors: Pierre Lanos, Liuming Zhou, Min Jia, Wenli Zhang, Bo Jiang, Wanmeng Mu, Tao Zhang
  • Patent number: 10557130
    Abstract: An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: February 11, 2020
    Assignee: Jiangnan University
    Inventors: Tao Zhang, Bo Jiang, Hangyu Jiang, Wanmeng Mu, Ming Miao
  • Patent number: 10351888
    Abstract: The invention discloses a high-efficiency synthesis method of difructose anhydride III. The method comprises the following steps: firstly converting sucrose into inulin by using inulosucrase without separating polysaccharide, and then converting inulin by using inulin fructotransferase to synthesize the functional disaccharide difructose anhydride III. The method has the advantages of simple process and high efficiency, and a conversion rate of synthesizing inulin into difructose anhydride III can reach 40%-54%. In order to obtain purer difructose anhydride III, yeast is utilized to remove small molecule monosaccharides in a reaction solution, and the finally obtained purer difructose anhydride III can be easily separated and purified. Thus, the method has broad market application prospects.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: July 16, 2019
    Assignee: Jiangnan University
    Inventors: Wanmeng Mu, Bo Jiang, Shuhuai Yu, Yingying Zhu, Tao Zhang
  • Publication number: 20190136219
    Abstract: A genetically engineered arginine deiminase reconstructed by site-directed mutagenesis belongs to the technical field of genetic engineering technology. Its amino acid sequence is shown as SEQ ID No. 1. In the amino acid sequence of the arginine deiminase reconstructed by site-directed mutagenesis, glycine at position 264 is mutated to proline, compared to an amino acid sequence of native arginine deiminase. Compared with wild type enzyme, the effective pH range effect of the mutated arginine deiminase according to the present invention is broadened to a certain extent, and especially a good enzyme activity is achieved at physiological pH 7.4. With the broadening of the effective pH effect range, the mutant enzyme still has higher stability under the condition of pH 5.5-7.5.
    Type: Application
    Filed: January 11, 2019
    Publication date: May 9, 2019
    Inventors: Tao ZHANG, Bo JIANG, Hangyu JIANG, Wanmeng MU, Ming MIAO
  • Publication number: 20190002939
    Abstract: The invention discloses a high-efficiency synthesis method of difructose anhydride III. The method comprises the following steps: firstly converting sucrose into inulin by using inulosucrase without separating polysaccharide, and then converting inulin by using inulin fructotransferase to synthesize the functional disaccharide difructose anhydride III. The method has the advantages of simple process and high efficiency, and a conversion rate of synthesizing inulin into difructose anhydride III can reach 40%-54%. In order to obtain purer difructose anhydride III, yeast is utilized to remove small molecule monosaccharides in a reaction solution, and the finally obtained purer difructose anhydride III can be easily separated and purified. Thus, the method has broad market application prospects.
    Type: Application
    Filed: April 15, 2016
    Publication date: January 3, 2019
    Inventors: Wanmeng MU, Bo JIANG, Shuhuai YU, Yingying ZHU, Tao ZHANG
  • Publication number: 20180251748
    Abstract: An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C.
    Type: Application
    Filed: February 28, 2018
    Publication date: September 6, 2018
    Inventors: Tao ZHANG, Bo JIANG, Hangyu JIANG, Wanmeng MU, Ming MIAO
  • Publication number: 20180179510
    Abstract: The present invention relates to an improved variant of a D-psicose 3-epimerase and its uses.
    Type: Application
    Filed: October 13, 2017
    Publication date: June 28, 2018
    Inventors: Pierre Lanos, Liuming Zhou, Min Jia, WenIi Zhang, Bo Jiang, Wanmeng Mu, Tao Zhang
  • Patent number: 9790481
    Abstract: The present invention relates to an improved variant of a D-psicose 3-epimerase and its uses.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: October 17, 2017
    Assignee: Roquette Frères
    Inventors: Pierre Lanos, Liuming Zhou, Min Jia, Wenli Zhang, Bo Jiang, Wanmeng Mu, Tao Zhang
  • Publication number: 20160281076
    Abstract: The present invention relates to an improved variant of a D-psicose 3-epimerase and its uses.
    Type: Application
    Filed: September 2, 2014
    Publication date: September 29, 2016
    Inventors: PIERRE LANOS, LIUMING ZHOU, MIN JIA, WENLI ZHANG, BO JIANG, WANMENG MU, TAO ZHANG